Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
D D D- D0 D1 D2 D5 D7 D8 D9 DA DB DC DD DE DF DG DH DI DJ DK DL DM DN DO DP DR DS DT DU DV DW DX DY
selected terms: 3,794
 << Prev ▫ 1 ▫ .. ▫ 30 ▫ 31 ▫ 32 ▫ 33 ▫ 34 ▫ 35 ▫ 36 ▫ .. ▫ 38 ▫ Next >>
 page 33 of 38

3201. Douche
[washing of a body cavity or surface for therapeutic purposes by flowing solution which is inserted and then removed; drugs in the irrigation solution may be absorbed. ( CSP )] (UMLS (NCI) C0022100) =Therapeutic or Preventive Procedure =Therapeutic Interventions;
RouteByMethod =bronchoalveolar lavage;
Irrigation, genitourinary;
Irrigation, intralesional;
Irrigation, intraocular;
Irrigation, urinary bladder;
Irrigation, intragastric;
Irrigation, rectal;
3251. DOX/IFF/MTP-PE Liposome/MTX
(UMLS (NCI) C0281526) =Therapeutic or Preventive Procedure
3202. Douche, vaginal
[Douche, vaginal ( HL7V3.0 )] (UMLS (HL7) C1553210) =Spatial Concept =VaginalRoute;
Douche
3252. DOX/IFF/MTX
(UMLS (NCI) C0279209) =Therapeutic or Preventive Procedure
3203. Doughnut Cell
(UMLS (NCI) C0427519) =Laboratory or Test Result
3253. DOX/IFF/PRED/VCR
(UMLS (NCI) C0279185) =Therapeutic or Preventive Procedure
3204. Douglas Indian Association
(UMLS (HL7) C1550847) =Population Group =NativeEntityAlaska;
3254. DOX/IFF/VCR
(UMLS (NCI) C0279210) =Therapeutic or Preventive Procedure
3205. Douroucoulis
[A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys. ( MSH )] (UMLS (CSP) C0003518) =Mammal
3255. DOX/IFF/VP-16
(UMLS (NCI) C0677752) =Therapeutic or Preventive Procedure ;
3206. Down syndrome
[A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features. ( NCI )] (UMLS (CSP) C0013080) =Congenital Abnormality; Disease or Syndrome ;
=Abnormalities, Multiple;
Chromosomal anomalies;
Arrieration mentale;
syndrome;
Chromosomal Disorders, Nervous System;
3256. DOX/IFN-A
(UMLS (NCI) C0338120) =Therapeutic or Preventive Procedure ;
3207. Down-Regulated in Rhabdomyosarcoma LIM Protein
[Members of the four-and-a-half-LIM domain (FHL) protein family, which are expressed in a tissue- and stage-specific manner, have been reported to function as transcriptional coactivators. Expression of DRAL (FHL2) results in enhancement of NF-kappaB activation. DRAL (FHL2) is a p53-responsive gene implicated in induction of apoptosis. DRAL may participate in a regulatory mechanism that coordinates cellular responses controlled by NF-kappaB transcription factor. (from J Biol Chem 2002;277:37045-53 and FEBS Lett 2002;521(1-3):165-9) ( NCI )] (UMLS (NCI) C1333635) FHL2;
Four and a Half LIM Domains 2;
Four and a Half LIM Domains 2 Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
3257. DOX/IL-2
(UMLS (NCI) C0278683) =Therapeutic or Preventive Procedure
3208. Down-Regulator of Transcription 1
[Encoded by human DR1 Gene, TATA-Binding Protein-Associated Phosphoprotein represses both basal and activated levels of transcription. DR1 phosphorylation affects its interaction with TBP. The DR1 protein contains a histone fold motif at the amino terminus, a TBP-binding domain, and a glutamine- and alanine-rich region and represses transcription with DRAP1 by inhibiting pre-initiation complex formation through interaction with TFIID and DNA. The binding of DR1 repressor complexes to TBP-promoter complexes may establish a mechanism in which an altered DNA conformation, together with the formation of higher order complexes, inhibits the assembly of the preinitiation complex and controls the rate of RNA polymerase II transcription. (NCI) ( NCI )] (UMLS (NCI) C0170954) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
3258. DOX/KCZ
(UMLS (NCI) C0281712) =Therapeutic or Preventive Procedure
3209. Down-Regulator of Transcription 1, TBP-Binding (Negative Cofactor 2) Gene
[This gene is involved in repression of transcription. ( NCI )] (UMLS (NCI) C1333247) DR1;
DR1 Gene;
=Gene or Genome ;
3259. DOX/L-PAM/MePRDL
(UMLS (NCI) C0281313) =Therapeutic or Preventive Procedure ;
3210. Downward Ocular Deviation
[Vertical strabismus in which there is permanent downward deviation of the visual axis of one eye. ( NCI )] (UMLS (NCI) C0152208) =Finding ;
3260. DOX/L-PAM/VM-26
(UMLS (NCI) C0279939) =Therapeutic or Preventive Procedure
3211. DOX-MTC
[A formulation of doxorubicin bound to microscopic beads of activated carbon and iron (magnetic targeted carriers). Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids. The placement of a magnet on the body surface overlying a tumor site facilitates this carrier complex to deliver doxorubicin directly to the tumor, thereby prolonging the duration of the therapeutic effects while decreasing systemic toxicity. ( NCI )] (UMLS (NCI) C1134452) Doxorubicin-Magnetic Targeted Carrier Complex;
MTC-DOX;
=Organic Chemical; Pharmacologic Substance
3261. DOX/MeCCNU
(UMLS (NCI) C0279380) =Therapeutic or Preventive Procedure
3212. DOX-SL
(UMLS (NCI) C0701182) =Organic Chemical; Pharmacologic Substance ;
3262. DOX/MeCCNU/SZC
(UMLS (NCI) C0279268) =Therapeutic or Preventive Procedure
3213. DOX/5-FU/GM-CSF/MTX
(UMLS (NCI) C0280205) =Therapeutic or Preventive Procedure
3263. DOX/MePRDL
(UMLS (NCI) C0796442) Doxorubicin/Methylprednisolone =Therapeutic or Preventive Procedure ;
3214. DOX/5-FU/L-PAM
(UMLS (NCI) C0279389) =Therapeutic or Preventive Procedure
3264. DOX/MITO
(UMLS (NCI) C0279188) =Therapeutic or Preventive Procedure
3215. DOX/5-FU/L-PAM/TMX
(UMLS (NCI) C0279796) =Therapeutic or Preventive Procedure
3265. DOX/MITO/VBL
(UMLS (NCI) C0052712) =Therapeutic or Preventive Procedure ;
3216. DOX/5-FU/MeCCNU
(UMLS (NCI) C0280593) =Therapeutic or Preventive Procedure
3266. DOX/MITO/VP-16
(UMLS (NCI) C0280065) =Therapeutic or Preventive Procedure
3217. DOX/5-FU/MITO/MTX
(UMLS (NCI) C0279534) =Therapeutic or Preventive Procedure
3267. DOX/MP/MTX/PRED/VCR
(UMLS (NCI) C0278924) =Therapeutic or Preventive Procedure
3218. DOX/5-FU/MITO/SZC
(UMLS (NCI) C0207828) =Therapeutic or Preventive Procedure
3268. DOX/MTX
(UMLS (NCI) C0281523) =Therapeutic or Preventive Procedure
3219. DOX/5-FU/MITO/TZT
(UMLS (NCI) C0279447) =Therapeutic or Preventive Procedure
3269. DOX/MTX/PRED/VCR
(UMLS (NCI) C0279197) =Therapeutic or Preventive Procedure
3220. DOX/5-FU/MITO/VCR
(UMLS (NCI) C0280592) =Therapeutic or Preventive Procedure
3270. DOX/MTX/VCR
(UMLS (NCI) C0280061) =Therapeutic or Preventive Procedure
3221. DOX/5-FU/MTX
(UMLS (NCI) C0051571) =Therapeutic or Preventive Procedure ;
3271. DOX/PCB/PRED/VCR
(UMLS (NCI) C0058827) =Therapeutic or Preventive Procedure ;
3222. DOX/5-FU/MTX/PRED/TSPA/VBL
(UMLS (NCI) C0279278) =Therapeutic or Preventive Procedure ;
3272. DOX/PCPZ
(UMLS (NCI) C0280750) =Therapeutic or Preventive Procedure
3223. DOX/5-FU/TMX/TSPA
(UMLS (NCI) C0280699) =Therapeutic or Preventive Procedure
3273. DOX/PEG-ASP/PRED/VCR
(UMLS (NCI) C0281219) =Therapeutic or Preventive Procedure ;
3224. DOX/5-FU/TSPA
(UMLS (NCI) C0280681) =Therapeutic or Preventive Procedure
3274. DOX/PRDL/VCR
(UMLS (NCI) C0281484) =Therapeutic or Preventive Procedure
3225. DOX/5-FU/TZT
(UMLS (NCI) C0279453) =Therapeutic or Preventive Procedure
3275. DOX/PRED
(UMLS (NCI) C0279013) =Therapeutic or Preventive Procedure ;
3226. DOX/5-FU/VBL
(UMLS (NCI) C0279998) =Therapeutic or Preventive Procedure
3276. DOX/PRED/VM-26
(UMLS (NCI) C0279511) =Therapeutic or Preventive Procedure
3227. DOX/5-FU/VNB
(UMLS (NCI) C0281298) =Therapeutic or Preventive Procedure
3277. DOX/PRED/VP-16
(UMLS (NCI) C0279891) =Therapeutic or Preventive Procedure
3228. DOX/DPPE
(UMLS (NCI) C0392975) =Therapeutic or Preventive Procedure ;
3278. DOX/progesterone
(UMLS (NCI) C0392995) =Therapeutic or Preventive Procedure
3229. DOX/DuP-941
(UMLS (NCI) C0338273) =Therapeutic or Preventive Procedure ;
3279. DOX/PSC 833
(UMLS (NCI) C0392966) =Therapeutic or Preventive Procedure ;
3230. DOX/EDAM
(UMLS (NCI) C0281407) =Therapeutic or Preventive Procedure ;
3280. DOX/QND
(UMLS (NCI) C0280652) =Therapeutic or Preventive Procedure
3231. DOX/EM
(UMLS (NCI) C0338295) =Therapeutic or Preventive Procedure
3281. DOX/QND/VP-16
(UMLS (NCI) C0279040) =Therapeutic or Preventive Procedure
3232. DOX/EM/KCZ/VBL
(UMLS (NCI) C0677757) =Therapeutic or Preventive Procedure
3282. DOX/SUR
(UMLS (NCI) C0280983) =Therapeutic or Preventive Procedure
3233. DOX/ESDL/TSPA/VBL/ZDX
(UMLS (NCI) C0280898) =Therapeutic or Preventive Procedure
3283. DOX/SZC
(UMLS (NCI) C0281271) =Therapeutic or Preventive Procedure
3234. DOX/Ethiodized Oil
(UMLS (NCI) C0280636) =Therapeutic or Preventive Procedure
3284. DOX/TAX
(UMLS (NCI) C0280905) =Therapeutic or Preventive Procedure
3235. DOX/FT/MITO
(UMLS (NCI) C0279365) =Therapeutic or Preventive Procedure
3285. DOX/TOPO
(UMLS (NCI) C0281396) =Therapeutic or Preventive Procedure ;
3236. DOX/FUDR
(UMLS (NCI) C0278914) =Therapeutic or Preventive Procedure
3286. DOX/Trifluoperazine/VBL/VPAM
(UMLS (NCI) C0281142) =Therapeutic or Preventive Procedure
3237. DOX/FUDR/MITO
(UMLS (NCI) C0280007) =Therapeutic or Preventive Procedure
3287. DOX/TSPA
(UMLS (NCI) C0280987) =Therapeutic or Preventive Procedure
3238. DOX/FXM/TMX/TSPA/VBL
(UMLS (NCI) C0279272) =Therapeutic or Preventive Procedure
3288. DOX/TSPA/VBL
(UMLS (NCI) C0279686) =Therapeutic or Preventive Procedure
3239. DOX/FXM/TSPA/VBL
(UMLS (NCI) C0075860) =Therapeutic or Preventive Procedure
3289. DOX/VBL
(UMLS (NCI) C0280930) =Therapeutic or Preventive Procedure
3240. DOX/G-CSF
(UMLS (NCI) C0281141) =Therapeutic or Preventive Procedure
3290. DOX/VBL/VP-16
(UMLS (NCI) C0255874) =Therapeutic or Preventive Procedure
3241. DOX/G-CSF/IFF
(UMLS (NCI) C0281618) =Therapeutic or Preventive Procedure
3291. DOX/VCR/VP-16
(UMLS (NCI) C0078136) =Therapeutic or Preventive Procedure
3242. DOX/G-CSF/MP/PRED/VCR
(UMLS (NCI) C0281131) =Therapeutic or Preventive Procedure
3292. DOX/VCR/VX-710
(UMLS (NCI) C0796603) Doxorubicin/Vincristine/VX-710 =Therapeutic or Preventive Procedure
3243. DOX/G-CSF/PRED/VCR
(UMLS (NCI) C0281132) =Therapeutic or Preventive Procedure
3293. DOX/VNB
(UMLS (NCI) C0281256) =Therapeutic or Preventive Procedure ;
3244. DOX/G-CSF/TAX
(UMLS (NCI) C0280906) =Therapeutic or Preventive Procedure
3294. DOX/VPAM
(UMLS (NCI) C0281009) =Therapeutic or Preventive Procedure
3245. DOX/G-CSF/TSPA
(UMLS (NCI) C0280986) =Therapeutic or Preventive Procedure
3295. DOX/VX-710
(UMLS (NCI) C0338355) =Therapeutic or Preventive Procedure ;
3246. DOX/GM-CSF
(UMLS (NCI) C0280753) =Therapeutic or Preventive Procedure
3296. Doxacurium Chloride
(UMLS (NCI) C0114872) =Organic Chemical; Pharmacologic Substance ;
=doxacurium;
=DOXACURIUM CHLORIDE 1 MG/ML
3247. DOX/GM-CSF/IFF
(UMLS (NCI) C0279011) =Therapeutic or Preventive Procedure ;
3297. DOXAPRAM
[A respiratory stimulant with analeptic activity. Doxapram, independent of oxygen levels, directly stimulates the peripheral carotid chemoreceptors, possibly by inhibiting the potassium channels of type I cells within the carotid body, thereby stimulating catecholamines release. This results in the prevention or reversal of both narcotic- and CNS depressant-induced respiratory depression. ( NCI )] (UMLS (NCI) C0013084) =Organic Chemical; Pharmacologic Substance ;
=Pyrrolidinones;
[RE900] RESPIRATORY AGENTS, OTHER =1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate
3248. DOX/HU
(UMLS (NCI) C0281440) =Therapeutic or Preventive Procedure
3298. DOXAZOSIN
[A quinazoline with antihypertensive and antineoplastic properties. Doxazosin is an alpha-adrenergic antagonist that selectively inhibits alpha-1 adrenergic receptors. Blockages of the alpha-1 adrenergic action on the vascular smooth muscles lead to a decrease in vascular resistance and antihypertensive activity. This agent also shows high affinity to alpha-1c adrenoceptor, the predominant functional type in the prostate, which may partially attribute to its effect in treatment of benign prostatic hyperplasia. Furthermore, doxazosin induces apoptosis in prostate cancer cells mediated through inhibition of protein kinase B (PKB)/Akt-signaling death receptor regulatory pathway. ( NCI )] (UMLS (NCI) C0114873) =Organic Chemical; Pharmacologic Substance ;
=1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine;
[CV150] ALPHA-BLOCKERS/RELATED =DOXAZOSIN MESYLATE
3249. DOX/ICI D1694
(UMLS (NCI) C0677753) =Therapeutic or Preventive Procedure ;
3299. Doxefazepam
(UMLS (NCI) C0114875) =Organic Chemical; Pharmacologic Substance ;
3250. DOX/IFF
(UMLS (NCI) C0278906) =Therapeutic or Preventive Procedure
3300. doxepin
[A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors. ( MSH )] (UMLS (CSP) C0013085) =Organic Chemical; Pharmacologic Substance ;
=[CN601] TRICYCLIC ANTIDEPRESSANTS;
Dibenzoxepins;
[DE900] DERMATOLOGICALS, TOPICAL OTHER;
=DOXEPIN HYDROCHLORIDE

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM